Endpoints News 2026年4月8日 Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
Endpoints News 2026年4月7日 Terns sold to Merck for 13% lower than pharma's initial offer because of clinical data
Endpoints News 2026年3月25日 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News 2026年3月24日 Merck partners with Flagship startup Quotient to search for genetic clues to IBD
Endpoints News 2025年12月18日 Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Endpoints News 2025年12月5日 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme